Inter Partes Patent Challenges Are Constitutional, US Supreme Court Rules
IPR process can continue, but the Patent Trial and Appeals Board must issue a final written decision on all claims raised by the challenger – not just some of them, court says; rulings in two closely watched cases mean that IPR proceedings can continue unabated, but challengers may need to rethink how they go about challenging innovator patent claims.
You may also be interested in...
The court has agreed to take an oil-industry case challenging patent office inter partes review procedures on the grounds they violate a constitutional right to trial by jury. IPRs have become an increasingly common approach in medtech and elsewhere for challenging patents outside of court, but not without controversy.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.